Skip to Content
MilliporeSigma
HomeServicesProduct ServicesSingle-Use and Filter Validation ServicesBacterial Retention Testing

Bacterial Retention Testing

Durapore® membrane with Opticap® Capsules and OptiScale® Capsule Filters

Bacterial Retention Testing (BRT) ensures that filters will produce a sterile effluent even when loaded with bacteria, making it a critical step in filter validation for biopharmaceutical manufacturers. This study is required by all regulatory bodies worldwide, including the United States Food and Drug Administration (FDA), European Union, Japan, and China Good Manufacturing Practices.

BioReliance® Validation Services testing is conducted in compliance with FDA’s Guidance on Sterile Drug Products Produced by Aseptic Processing, as well as testing parameters established by the Parenteral Drug Association’s (PDA) Technical Report 26. All bacterial retention tests are performed in controlled laboratories with calibrated equipment and methods governed by our robust quality system.

Challenging each membrane with worst-case experiments

Our test approach is to utilize end-user worst-case processing conditions to determine the ability of a sterilizing-grade filter to retain a minimum challenge of 107 bacteria per cm2 of filter area. By using this worst-case approach, we ensure a best-case outcome for you.

  • Brevundimonas diminuta (B. diminuta) is commonly used as a challenge microorganism. With appropriate justification from your bioburden characterization, we can also use other strains for testing.
  • Every lab strictly adheres to Parenteral Drug Product (PDA) guidelines and American Society for Testing and Materials (ASTM) standards.
  • A robust and compliant challenge consists of one lot of finished drug product or process fluid to be evaluated using three lots of MilliporeSigma sterilizing-grade, 47 mm membrane discs.
  • At least one membrane is included at or near the minimum integrity specification.
  • Size controls prove that the test organism has the appropriate size.
  • Preliminary studies are included, such as viability testing to select the appropriate challenge solution and a recovery test to ensure that any possible bacteria can be recovered on the collection filters.
  • Process conditions with your drug product are simulated to provides empirical evidence.

Request a quote and get started today.

Trust our Global Services Network

To learn more about our industry-leading validation services for biopharmaceutical manufacturers, look into these specialized capabilities performed at our laboratories worldwide.

  • Singe-Use and Filter Validation Services
  • Chemical Compatibility Testing
  • Filter Integrity Testing
  • Extractables and Leachables
  • Validation Services Consultancy
  • Validation Service Levels

Related Product Resources

Webinar: The Proof is in the Pudding: Bacterial Retention of Sterilizing Grade Membranes
White Paper: Effect of Membrane Filter Pore Size on Microbial Recovery and Colony Morphology
White Paper: Retention of Small Organisms by 0.22 μm Durapore® Filter

Related Services
Single-Use and Filter Validation Services
Accelerate and simplify your path to market by using our BioReliance® Validation Services to select, test, and validate your filters, assemblies, and single-use systems for drug manufacturing and processing.
Chemical Compatibility Testing
Our physical and chemical compatibility testing services help you comply with GMP guidelines worldwide, proving that your biopharmaceutical filters and single-use systems are not reactive, additive, or absorptive upon contact with drug product.
Filter Integrity Testing
Our integrity testing for sterilizing-grade filters can help you set a test specification for your drug product, then check for leaks or filter damage using pre-use and post-use testing as recommended or required by regulatory agencies and the Parenteral Drug Association (PDA).
Extractables and Leachables
Proving that extractables and leachables from your process aren’t harmful to the final drug product is easier with BioReliance® Validation Services. Our extractables and leachables (E&L) services thoroughly evaluate all contact materials and processes to mitigate concerns about process fluids.
Validation Services Consultancy
For local assistance and rapid response to your filtration validation needs, BioReliance® Validation Services offers a global network of highest-quality laboratories with in-country and in-region experts at strategic geographic centers.
Validation Service Levels
Discover an easier way to global compliance with our validation services, simplifying your process from the start with two predefined service levels and globally harmonized testing.
Related Applications
Monoclonal Antibody Manufacturing
Monoclonal antibody manufacturing is a highly templated approach used to produce mAb-based immunotherapies. Robust, scalable process solutions are required at every step to ensure high therapeutic concentration and process safety, while meeting speed-to-market and cost containment concerns.
Classical Pharmaceutical Formulation & Manufacturing
Manufacturing the final dosage form of a small molecule drug requires robust quality and design in development of the formulation and production of the final product. Explore solutions and best practices to advance and accelerate small molecule pharmaceuticals, from development to commercialization.
Gene Therapy Manufacturing
Growing use of gene therapies is driving rapid innovation in an evolving global market. Manufacturers bringing new gene therapies to life face complex challenges, requiring an experienced partner capable of integrating vector manufacturing, testing, safety, process development, and regulatory compliance.
Vaccine Manufacturing
From early phase development, through downstream purification to large scale vaccine production: learn more about vaccine process development and application expertise.
Sign In To Continue

To continue reading please sign in or create an account.

Don't Have An Account?